Zhejiang Huahai Pharmaceutical Co Ltd (600521) — Tangible Net Worth Ratio
Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Tangible Net Worth Ratio of 77.4% as of March 2026. This metric is calculated by deducting intangible assets (CN¥2.23 Billion) from net assets (CN¥9.85 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See shareholders equity of Zhejiang Huahai Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zhejiang Huahai Pharmaceutical Co Ltd Tangible Net Worth Ratio (2000–2025)
This chart shows how Zhejiang Huahai Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 26 annual periods from 2000 to 2025. As of March 2026, the ratio stands at 77.4%, reflecting net assets of CN¥9.85 Billion with intangible assets of CN¥2.23 Billion CNY. Also explore Zhejiang Huahai Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Zhejiang Huahai Pharmaceutical Co Ltd (2000–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Huahai Pharmaceutical Co Ltd from 2000 to 2025, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 600521 market cap.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 76.5% | CN¥9.46 Billion | CN¥2.22 Billion | CN¥21.50 Billion | ▼ 0.0 pp |
| 2024 | 76.5% | CN¥9.02 Billion | CN¥2.12 Billion | CN¥20.26 Billion | ▼ -0.3 pp |
| 2023 | 76.9% | CN¥8.25 Billion | CN¥1.91 Billion | CN¥18.60 Billion | ▼ -0.1 pp |
| 2022 | 77.0% | CN¥7.75 Billion | CN¥1.78 Billion | CN¥18.15 Billion | ▼ -1.3 pp |
| 2021 | 78.3% | CN¥6.78 Billion | CN¥1.47 Billion | CN¥15.47 Billion | ▼ -4.1 pp |
| 2020 | 82.4% | CN¥6.72 Billion | CN¥1.19 Billion | CN¥12.99 Billion | ▼ -1.2 pp |
| 2019 | 83.6% | CN¥5.78 Billion | CN¥948.20 Million | CN¥10.73 Billion | ▲ +4.1 pp |
| 2018 | 79.5% | CN¥4.21 Billion | CN¥864.07 Million | CN¥10.37 Billion | ▼ -6.6 pp |
| 2017 | 86.1% | CN¥5.05 Billion | CN¥704.39 Million | CN¥8.27 Billion | ▼ -3.4 pp |
| 2016 | 89.4% | CN¥4.58 Billion | CN¥482.98 Million | CN¥6.73 Billion | ▲ +0.8 pp |
| 2015 | 88.7% | CN¥3.72 Billion | CN¥421.00 Million | CN¥5.52 Billion | ▼ -0.6 pp |
| 2014 | 89.3% | CN¥3.27 Billion | CN¥349.71 Million | CN¥4.51 Billion | ▼ -2.5 pp |
| 2013 | 91.8% | CN¥3.02 Billion | CN¥247.18 Million | CN¥4.47 Billion | ▲ +3.8 pp |
| 2012 | 88.0% | CN¥1.95 Billion | CN¥232.95 Million | CN¥3.22 Billion | ▼ -4.2 pp |
| 2011 | 92.2% | CN¥1.53 Billion | CN¥118.55 Million | CN¥2.58 Billion | ▲ +0.9 pp |
| 2010 | 91.3% | CN¥1.32 Billion | CN¥114.44 Million | CN¥2.05 Billion | ▲ +0.1 pp |
| 2009 | 91.2% | CN¥1.21 Billion | CN¥106.83 Million | CN¥1.74 Billion | ▲ +0.3 pp |
| 2008 | 90.9% | CN¥1.10 Billion | CN¥100.78 Million | CN¥1.52 Billion | ▲ +0.3 pp |
| 2007 | 90.6% | CN¥975.52 Million | CN¥91.89 Million | CN¥1.26 Billion | ▼ -7.8 pp |
| 2006 | 98.4% | CN¥875.40 Million | CN¥13.90 Million | CN¥1.10 Billion | ▲ +0.2 pp |
| 2005 | 98.2% | CN¥802.34 Million | CN¥14.22 Million | CN¥975.04 Million | ▲ +0.1 pp |
| 2004 | 98.1% | CN¥785.53 Million | CN¥14.65 Million | CN¥895.55 Million | ▼ -1.2 pp |
| 2003 | 99.3% | CN¥685.42 Million | CN¥4.84 Million | CN¥774.68 Million | ▲ +5.2 pp |
| 2002 | 94.1% | CN¥80.56 Million | CN¥4.74 Million | CN¥248.18 Million | ▲ +0.9 pp |
| 2001 | 93.2% | CN¥72.15 Million | CN¥4.88 Million | CN¥223.88 Million | ▲ +0.9 pp |
| 2000 | 92.4% | CN¥65.23 Million | CN¥4.98 Million | CN¥178.02 Million | — |